follitropin alfa: Clinical Trials

114 trials of follitropin alfa, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

76 completed, 18 unknown, 11 terminated, 3 active not recruiting. 35 Phase 4, 29 Phase 3, 14 Phase 2, 13 Not applicable, 13 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 435Completed 17, Unknown 8, Terminated 6, Withdrawn 2, Active not recruiting 1, Not yet recruiting 1
Phase 329Completed 25, Unknown 3, Terminated 1
Phase 214Completed 7, Unknown 5, Terminated 2
Not applicable13Completed 8, Recruiting 2, Unknown 2, Active not recruiting 1
Phase 113Completed 9, Unknown 3, Active not recruiting 1
Early Phase 12Completed 2

Follow this drug Literature Review of follitropin alfa trials Research Report on follitropin alfa

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
225 IU Versus 300 IU Starting FSH Dose in PPOS for Good-Prognosis Women
Follitropin Alfa (Follitrope) - Infertility (IVF Patients), Infertility Assisted Reproductive Technology
Not applicableRecruitingVietnam Military Medical University3802026-09-152026-10-20
Study on the Pharmacokinetics and Safety of QL1012D and Gonal-F® in Healthy Female Volunteers
QL1012D, Gonal-F® - Infertility, Female
Phase 1Active not recruitingQilu Pharmaceutical Co., Ltd.482025-04-062026-02-17
Phase IV Study to Evaluate the Efficacy and Safety of Fang Le Shu Compared to Guo Na Fen for Controlled Ovarian Stimulation in Infertile Women Undergoing in Vitro Fertilization-embryo Transfer (IVF-ET).
Fang Le Shu (Follitrope), Guo Na Fen (Gonal-F) - Female Infertility
Phase 4Active not recruitingLG Chem2482025-02-152026-09-02
Serum FSH Monitoring for Identification of an Optimal Range During Ovarian Stimulation
Gonal-f (gonadotropin) - Ovarian Stimulation
RecruitingART Fertility Clinics LLC1502024-12-162026-06-25
Potential Benefit of r-hLH Addition in Patients Aged 35 to 40 Under Ovarian Stimulation Treatment
Recombinant Human Follitropin Alfa Solution for Injection (Gonal-f®), Recombinant Human Lutropin alfa for Injection (r-hLH, Luveris®) - Infertility
Phase 4Not yet recruitingNanjing University3002024-09-012024-08-27
Possible Action of Resveratrol in Improving the Outcomes of IVF/ICSI in Couples With Unexplained Infertility
Resveratrol-based multivitamin supplement, Folic acid, IVF/ICSI - Unexplained Infertility
Not applicableUnknownAndros Day Surgery Clinic902024-06-012024-07-01
A Randomised Trial Comparing the Ovarian Response of a Starting Dose of Either 10 μg or 15 μg Follitropin Delta (FE 999049) to a Starting Dose of Either 150 IU or 225 IU Follitropin Alfa (GONAL-F) in Conventional Regimens in China
FE 999049, GONAL-F - Infertility, Female
Phase 3CompletedFerring Pharmaceuticals3012024-03-292026-02-12
Extra Luteinizing Hormone Improve Embryo Quality in IVF Patients With Low LH During Long GnRH-Agonist Treatment
Recombinant Luteinizing Hormone (rLH), Recombinant Follicle-Stimulating Hormone (rFSH), Gonadotropin-Releasing Hormone Agonist (GnRH-a) - Infertility, Female, Luteinizing Hormone (LH)
Not applicableRecruitingNanjing University5902024-02-012025-08-19
Effect of LH Supplementation on the Endometrial Gene Expression Profile in Poor Ovarian Responders
Lutropin alfa, Follitropin alfa, Endometrial biopsy - Poor Response to Ovulation Induction
Phase 4WithdrawnCRG UZ Brussel2023-05-012024-02-28
To Investigate Efficacy and Safety of a Single Injection of GenSci094 for Ovarian Stimulation Using Daily Recombinant FSH as Reference
GenSci094, Placebo RecFSH / follitropin alfa, Biological: RecFSH / Follitropin alfa (Days 1 to 7) - Infertility
Phase 3CompletedChangchun GeneScience Pharmaceutical Co., Ltd.1762023-03-242024-12-03
Continuous Double Ovarian Stimulation.
Corifollitropin Alfa, Follitropin Alfa, Follitropin Alfa Biosimilar - Fertility Issues
Phase 4CompletedInstituto Bernabeu302022-11-172025-05-18
Recombinant Follicle-stimulating Hormone in Treatment for Infertility
Recombinant Human Follicle Stimulating Hormone 900 IU (66.0 μg) / 1.5mL Solution for Injection in Prefilled Pen - Female Infertility
Phase 3UnknownBharat Serums and Vaccines Limited2502022-07-232023-08-01
A Trial to Compare the Ovarian Response of REKOVELLE and GONAL-F in Conventional Dosing in Women Undergoing Controlled Ovarian Stimulation
REKOVELLE (Follitropin Delta), GONAL-F (Follitropin Alfa) - Infertility
Phase 3CompletedFerring Pharmaceuticals3022022-07-152025-04-02
Effectiveness of Low Dose Gonadotropin Stimulation Protocol Vs High Dose Gonadotropin Protocol in Poor Responders
Clomiphane citrate, recombinant human Follicle-Stimulating Hormone (r-FSH-alfa) - Female Infertility
Early Phase 1CompletedUniversity of Athens222022-01-012025-01-16
Efficacy and Safety of FE 999049 in Controlled Ovarian Stimulation in Indian Women
Follitropin Delta (FE 999049), Follitropin Alfa (GONAL-F) - Infertility
Phase 3CompletedFerring Pharmaceuticals2202021-12-032025-01-24
Cumulative Pregnancy Rate With Lower and Higher Gonadotropin Dose During IVF Among Poor Responders
Follitropin Alfa, Follitropin delta, human menopausal gonadotropin - Infertility, Ovarian Dysfunction
Not applicableCompletedPeter Kovacs MD1902021-12-022024-12-13
Growth Hormone Pretreatment in Poseidon Type IV Undergoing ICSI Using Minimal Induction Protocol: A Randomized Controlled Trial
Growth Hormone, Clomiphene citrate daily and recombinant FSH (Gonal-F®) - Poor Response to Ovulation Induction Poseidon Type IV
Not applicableUnknownAin Shams Maternity Hospital1322021-10-092021-10-22
Pergoveris FD and Liquid China BE Study
Pergoveris FD, Pergoveris Liquid, Gonal-f - Healthy
Phase 1CompletedMerck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany722021-05-082022-06-15
Estradiol and Progesterone Levels Following Frozen Embryo Transfer
Estradiol Tablets, Progesterone, Follitropin Alfa - Infertility
Phase 4CompletedCopenhagen University Hospital at Herlev3052021-04-202025-01-03
Bioequivalence Clinical Trial of Recombinant Human Follicle-stimulating Hormone JZB30
Gonal F, jzb30 - Bioequivalence, Healthy Volunteers
Phase 1CompletedWest China Second University Hospital482021-01-042025-01-16

Showing 20 of 114. Sign in to see all of them.

Conditions studied

Infertility (65)  ·  Infertility, Female (14)  ·  Helping Behavior (9)  ·  Polycystic Ovary Syndrome (6)  ·  Anovulation (3)  ·  Hypogonadism (3)  ·  Ovarian Hyperstimulation Syndrome (3)  ·  Infertility, Male (2)  ·  Aneuploidy (1)  ·  Embryo Loss (1)  ·  Genital Diseases, Female (1)  ·  Kallmann Syndrome (1)  ·  Neoplasms (1)  ·  Primary Ovarian Insufficiency (1)  ·  Progesterone Resistance (1)

Sponsors

Merck KGaA, Darmstadt, Germany (25)  ·  Ferring Pharmaceuticals (11)  ·  Glycotope GmbH (3)  ·  IVFarma LLC (3)  ·  ART Fertility Clinics LLC (2)  ·  Andros Day Surgery Clinic (2)  ·  Changchun GeneScience Pharmaceutical Co., Ltd. (2)  ·  EMD Serono (2)  ·  IBSA Institut Biochimique SA (2)  ·  Nanjing University (2)  ·  Organon and Co (2)  ·  Qilu Pharmaceutical Co., Ltd. (2)  ·  University of Athens (2)  ·  University of California, San Diego (2)  ·  Vietnam National University (2)

Countries

China (14)  ·  Germany (10)  ·  United States (10)  ·  Italy (9)  ·  Denmark (8)  ·  France (8)  ·  Spain (8)  ·  United Kingdom (8)  ·  Russia (7)  ·  Belgium (4)  ·  Canada (4)  ·  Egypt (4)  ·  Netherlands (4)  ·  Poland (4)  ·  Vietnam (4)

Top investigators

Adolfo Allegra, MD (2)  ·  Tuong M Ho, MD (2)  ·  Ahmed Gibreel, MD (1)  ·  Ahmed Maged, MD (1)  ·  Alberto Revelli, MD PhD (1)  ·  Alexdandr Gzgzyan, Prof, PhD (1)  ·  Allison M Case, MD FRCSC (1)  ·  Anders N Andersen, professor (1)  ·  Angela R Baerwald, PhD (1)

Results publications

PMID 27912901, PMID 28591833, PMID 30801744, PMID 32819842, PMID 34254211, PMID 37156263, PMID 12748128, PMID 16740654, PMID 17007663, PMID 17110397, PMID 17222700, PMID 18024487, PMID 18175787, PMID 18230195, PMID 18765009, PMID 19136673, PMID 19684043, PMID 20031032, PMID 20362973, PMID 20373015, PMID 20483664, PMID 21505041, PMID 21558332, PMID 21575849, PMID 21575853, PMID 22791757, PMID 22819187, PMID 23249758, PMID 23312225, PMID 23507133, PMID 23809501, PMID 24037890, PMID 24077980, PMID 24129613, PMID 24161646, PMID 24929258, PMID 24942155, PMID 24970684, PMID 25362088, PMID 25444501, PMID 25596910, PMID 25740882, PMID 26141305, PMID 26194884, PMID 26315293, PMID 26621118, PMID 26921622, PMID 26950065, PMID 26991902, PMID 28137754

NIH funding

2004 (1), 2005 (1), 2008 (1), U54HD028138 (1)